1 / 2

Morphine, Buprenorphine, and Other Drugs Market

The global Morphine, buprenorphine, and other drugs market size was valued at USD 7,700 million in 2021 and is projected to reach around USD 12,500 million in 2030 exhibiting a CAGR of 5.2% in the forecasted period.

vikas94
Download Presentation

Morphine, Buprenorphine, and Other Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Morphine, Buprenorphine, and Other Drugs MarketWill Record Rapid Growth, Trend Analysis till 2030 The global Morphine, buprenorphine, and other drugs market size was valued at USD 7,700 million in 2021 and is projected to reach around USD 12,500 million in 2030 exhibiting a CAGR of 5.2% in the forecasted period. The growing approval of drugs for opioid addiction treatment is projected to increase the market growth. Additionally, increasing advanced work practices by scholarly foundations will support in creating profitable openings for important market players. For instance, in April 2018, Stanford University Bioengineers adopted another anticancer medication and hack suppressant medication noscapine by added technique for construction in light of maturation of catalysts developed from therapeutic plants, vertebrates, and microorganisms to make the drug. However, overdose of opioids which leads to death, increasing number of litigations that affects the drug approvals will act as a restriction for the growth of this market. Request https://wemarketresearch.com/reports/request-free-sample-pdf/morphine-buprenorphine- and-other-drugs-market/865 Free Sample Copy of this Report@ The major drivers backing to the global morphine, buprenorphine and other drug market's growth is the increase in prevalence of diseases such as cancer, arthritis, chronic pain, and fibromyalgia. Numerous narcotic drugs are endorsed for the management of moderate to severe pain in cancer patients. For instance, according to Centers for Disease Control and Prevention (CDC) cancer is among the leading causes of deaths in the U.S. Moreover, as per the U.S. Cancer Statistics of 2021 in 2018 1,708,923 Americans were detected with cancer. Thus, due to prevalence of cancer and use of opioids for treatment of cancer is projected to drive the market growth. Coronavirus has impacted the economy in after ways; originally by influencing establishment and demand, then, by creating worsening in distribution channels, and in conclusion over the monetary effect on financial markets and firms. Due to lockdowns across the world, India, Saudi Arabia, China, Egypt, UAE, and others are dealing with issues regarding the transportation of opioid drugs. Additionally, disease patients can’t visit hospitals for the management of opioid treatment due to lockdowns and COVID-19 restrictions which is further restraining the market development. Consequently, morphine, buprenorphine, and other drugs market is unfavourably impacted due to the COVID-19 pandemic. Besides, the turn of actions and send-off of opioid drugs is depended upon to help with the growth of the global morphine, buprenorphine, and other drugs market. For instance, in March 2019, Piramal Critical Care sent off the Morphine Sulfate infusion in the U.S. with the brand name of Mitigo used for obstinate ongoing pain cure.

  2. Morphine Sulfate infusion is consumed for getting moderate grave pain. It is considerably used for pain associated with a myocardial infarction, medical procedure, and malignant development. Therefore, such send-off of new substances is relied upon to boost the morphine, buprenorphine, and other drugs market. Secure https://wemarketresearch.com/purchase/morphine-buprenorphine-and-other-drugs- market/865?license=single A Copy Of The Premium Research Report@ Competitive Analysis Purdue Pharma, Sun Pharmaceuticals, Pfizer Inc., West Ward Pharmaceuticals, Teva Pharmaceuticals, Piramal Pharmaceuticals, Hikama Pharmaceuticals, Indivior PLC, Oreoxo AB, Camurus AB, Novartis. About We Market Research: WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep-rooted market studies and insightful analysis of different markets. Contact Us: We Market Research Phone: +1(650)-666-4592 Email: sales@wemarketresearch.com Web: https://wemarketresearch.com/

More Related